Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2010

Jun 11, 2010

34807_dirs_2010-06-11_9fe42fc3-d3ee-4a30-82c9-fbed5ece2701.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2010-06-07

Reporting Person: SKLAR JEFFREY L (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-06-07 Purchase Option $0.58 A 5000 Acquired 2020-06-06 Common Stock (5000) Direct

Footnotes

F1: Common Stock, par value $.01 per share of Transgenomic, Inc.